Unavailable
Unavailable
Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.
4 - CHASE CORP (0000830524) (Issuer)
4 - CHASE CORP (0000830524) (Issuer)
4 - CHASE CORP (0000830524) (Issuer)
Revenue Increased 37.2% to $103 Million Year Over Year NuCera Business Integration Progressing, Elevating Company-Wide Results While Expanding Geographic Footprint and Specialized Product Offerings Chase Corporation (NYSE:CCF), a global specialty chemicals company that is a leading manufacturer of protective materials for high-reliability applications across diverse market sectors, today announced financial results for the first fiscal quarter ended November 30, 2022. Fiscal First Quarter Financial and Recent Operational Highlights Total Revenue grew 37.2% to $103 million, primarily attributed to inorganic growth from the NuCera business which was acquired in the first month of Q1 FY23
Revenue Increased by 12.7% to $88 Million in Q4 FY22 compared to Q4 FY21 Gross Margin improved from first half of fiscal 2022 ending the year at 37.8% Declares Dividend of $1.00 Per Share Chase Corporation (NYSE:CCF), a global specialty chemicals company that is a leading manufacturer of protective materials for high-reliability applications across diverse market sectors, announced financial results for the fourth fiscal quarter ended August 31, 2022. The Company also announced a cash dividend of $1.00 per share to shareholders of record on November 30, 2022, payable on December 9, 2022. Fiscal Fourth Quarter Financial and Recent Operational Highlights Total Revenue grew 12.7% to $88
Transformative acquisition expands the Company's suite of specialty polymers and attractive polymerization technologies, advancing Chase Corp's portfolio of products, customer reach and strategic growth trajectory Chase Corporation (NYSE:CCF), a leading global manufacturer of protective materials for high-reliability applications across diverse market sectors, today announced that it has entered into a definitive agreement to acquire NuCera Solutions, ("NuCera" or the "Company") from SK Capital (a private equity firm headquartered in New York). NuCera is a recognized global leader in the production and development of highly differentiated specialty polymers and polymerization technologies
SC 13G/A - CHASE CORP (0000830524) (Subject)
SC 13G/A - CHASE CORP (0000830524) (Subject)
SC 13G/A - CHASE CORP (0000830524) (Subject)
Inogen, Inc. (NASDAQ:INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Michael Bourque as Chief Financial Officer, effective March 4, 2024. Mr. Bourque has served as Treasurer and Chief Financial Officer of Chase Corporation (NYSE:CCF) now owned by KKR & Co. Inc. He succeeds Interim Chief Financial Officer Mike Sergesketter, who will remain in an advisory role during the transition. Mr. Bourque has served as Chief Financial Officer and Treasurer of Chase Corporation since 2021. He also served as Chief Financial Officer of Keystone Dental, Senior Vice President, Chief Financial Officer and Treasu
Chase Corporation ("Chase" or the "Company"), a leading global manufacturer of protective materials for high-reliability applications across diverse market sectors, today announced the successful completion of its acquisition by affiliates of KKR, a leading global investment firm, for $127.50 per share. As a result of the completion of the transaction, Chase common stock has ceased trading and will no longer be listed on the NYSE American. "Today represents an important milestone for Chase in our journey to better serve our customers through strategic growth and innovation," said Adam Chase, President and Chief Executive Officer of Chase. "From the beginning, KKR was a strong cultural fit
Chase Corporation ("Chase" or the "Company") (NYSE:CCF), a leading global manufacturer of protective materials for high-reliability applications across diverse market sectors, held a special meeting of shareholders earlier today (the "Special Meeting") at which Chase shareholders approved the transactions contemplated by that certain Agreement and Plan of Merger (the "Merger Agreement") dated July 21, 2023 by and among Chase, Formulations Parent Corporation ("Parent") and Formulations Merger Sub Corporation ("Merger Sub"). Pursuant to the Merger Agreement, Merger Sub will merge with and into Chase, with Chase surviving as a wholly owned subsidiary of Parent (the "Merger"). Parent and Merger
15-12G - CHASE CORP (0000830524) (Filer)
EFFECT - CHASE CORP (0000830524) (Filer)
S-8 POS - CHASE CORP (0000830524) (Filer)
Inogen, Inc. (NASDAQ:INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Michael Bourque as Chief Financial Officer, effective March 4, 2024. Mr. Bourque has served as Treasurer and Chief Financial Officer of Chase Corporation (NYSE:CCF) now owned by KKR & Co. Inc. He succeeds Interim Chief Financial Officer Mike Sergesketter, who will remain in an advisory role during the transition. Mr. Bourque has served as Chief Financial Officer and Treasurer of Chase Corporation since 2021. He also served as Chief Financial Officer of Keystone Dental, Senior Vice President, Chief Financial Officer and Treasu
Chase Corporation (NYSE:CCF), a global specialty chemicals company that is a leading manufacturer of protective materials for high-reliability applications across diverse market sectors, announced on July 14, 2022 that the Board of Directors elected Ellen Rubin to the Board, as an independent director, effective immediately. Additionally, she will serve as a member of Chase's Audit Committee. Peter Chase, Chairman of the Board, commented "We are thrilled to be adding Ellen Rubin's leadership, industry knowledge, and expertise to our Board of Directors as we continue to expand our business, drive scale, and deliver against our proven growth strategy. Ms. Rubin brings to our Board an extensi
WESTWOOD, Mass.--(BUSINESS WIRE)--Chase Corporation (NYSE American: CCF), a global specialty chemicals company that is a leading manufacturer of protective materials for high-reliability applications across diverse market sectors, today announced financial results for the quarter ended November 30, 2020, the first quarter of its fiscal year 2021. Fiscal First Quarter Key Highlights Total Revenue of $67.2 million, up compared to $66.8 million in the prior year Gross Margin of 41%, up compared to 37% in the prior year Net Income of $10.8 million, up compared to $7.4 million in the prior year Adjusted EBITDA of $18.1 million, up compared to $14.7 million in the prior year